Published December 9, 2021
Health magazine published a story about the HIV preventative medication pre-exposure prophylaxis (PrEP) quoting Seth Glassman, an assistant clinical professor of medicine at the Jacobs School of Medicine and Biomedical Sciences. "For primary care doctors who don't deal with a lot of HIV or deal with people with high-risk lifestyles, having the CDC give the green light and say that this is an expected and routine part of your care potentially gives license to providers who otherwise might not have had this conversation," said Glassman, an infectious disease expert who focuses on HIV.